George J N, Potterf R D, Lewis P C, Sears D A
J Lab Clin Med. 1976 Aug;88(2):232-46.
A polar, nonpenetrating compound of high specific activity, diazotized (125I)-diiodosulfanilic acid (DD125ISA), has been developed as a label for exposed proteins of the human platelet plasma membrane, and platelet proteins and the pattern of labeling have been studied with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). That DD125ISA binds specifically to membrane proteins was demonstrated by: (1) the specific activity of isolated membrane protein was five to seven times that of whole platelet protein and (2) no proteins of intact platelets were labeled which were not represented in the isolated plasma membrane. That the DD125ISA-labeled membrane proteins were exposed on the cell surface was demonstrated by: (1) DD125ISA-labeled proteins were altered by trypsin treatment of intact, labeled platelets and (2) the pattern of labeling produced by reaction of isolated membranes with DD125ISA was quite different from that produced by the labeling of intact platelets. Analysis of platelet membrane proteins by SDS-PAGE demonstrated the glycoproteins previously described at 150,000 daltons (termed glycoprotein I) and 92,000 daltons (glycoprotein III) but we could discriminate two apparently distinct glycoproteins in the intermediate region (IIa: 125,000 daltons, and II: 118,000 daltons). Glycoproteins I and III were constant whereas IIa was clearly visible only in unreduced samples and II was predominant in reduced samples. Reaction of DD125ISA with intact platelets resulted in equal labeling of three of these four membrane glycoproteins (IIa, II, and III). The pattern of exposed proteins on the platelet surface labeled by DD125ISA was different from lactoperoxidase-131I, which labeled predominantly the 92,000 dalton glycoprotein, as demonstrated by simultaneous SDS-PAGE analysis. Therefore three glycoproteins of the human platelet plasma membrane are exposed to a radioisotope probe on the platelet surface and are accessible for contact interactions.
一种具有高比活性的极性、非穿透性化合物,重氮化(125I)-二碘磺胺酸(DD125ISA),已被开发用作人血小板质膜暴露蛋白的标记物,并且已通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)研究了血小板蛋白及其标记模式。DD125ISA与膜蛋白的特异性结合通过以下方式得到证明:(1)分离的膜蛋白的比活性是全血小板蛋白的五到七倍,以及(2)完整血小板中未被标记的蛋白在分离的质膜中也未出现。DD125ISA标记的膜蛋白暴露在细胞表面通过以下方式得到证明:(1)用胰蛋白酶处理完整的、标记的血小板会改变DD125ISA标记的蛋白,以及(2)分离的膜与DD125ISA反应产生的标记模式与完整血小板标记产生的模式有很大不同。通过SDS-PAGE分析血小板膜蛋白,证实了先前描述的150,000道尔顿(称为糖蛋白I)和92,000道尔顿(糖蛋白III)的糖蛋白,但我们可以在中间区域区分出两种明显不同的糖蛋白(IIa:125,000道尔顿,和II:118,000道尔顿)。糖蛋白I和III是恒定的,而IIa仅在未还原的样品中清晰可见,II在还原样品中占主导地位。DD125ISA与完整血小板反应导致这四种膜糖蛋白中的三种(IIa、II和III)有相同的标记。如通过同时进行的SDS-PAGE分析所示,DD125ISA标记的血小板表面暴露蛋白的模式与乳过氧化物酶-131I不同,后者主要标记92,000道尔顿的糖蛋白。因此,人血小板质膜的三种糖蛋白暴露在血小板表面的放射性同位素探针下,并且可用于接触相互作用。